BUDGET IMPACT ANALYSIS (BIA) OF CABAZITAXEL INTRODUCTION IN TREATMENT OF METASTATIC HORMONE-REFRACTORY PROSTATE CANCER (MHRPC) IN RUSSIAN FEDERATION

被引：0

作者：

Yagudina, R. ^{[1
]}

Kulikov, A. ^{[1
]}

Kogon, L. ^{[2
]}

机构：

[1] IM Sechenov First Moscow State Med Univ, Moscow, Russia

[2] FGBU NCESMP Minist Hlth Russia, Moscow, Russia

来源：

VALUE IN HEALTH | 2013年 / 16卷 / 03期

关键词：

D O I：

10.1016/j.jval.2013.03.640

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

页码：A132 / A132

页数：1

共 50 条

[21] Satraplatin in the treatment of hormone-refractory prostate cancer
Sternberg, CN
BJU INTERNATIONAL, 2005, 96 (07) : 990 - 994
[22] Pyrazoloacridine for the treatment of hormone-refractory prostate cancer
Small, EJ
Fippin, LJ
Whisenant, SP
CANCER INVESTIGATION, 1998, 16 (07) : 456 - 461
[23] Chemotherapy for the treatment of hormone-refractory prostate cancer
Petrylak, DP
EUROPEAN UROLOGY SUPPLEMENTS, 2002, 1 (02) : 15 - 23
[24] The role of doxorubicin and epirubicin for the treatment of patients with metastatic hormone-refractory prostate cancer
Petrioli, Roberto
Pascucci, Alessandra
Francini, Edoardo
Fiaschi, Anna Ida
Sciandivasci, Angela
Miano, Salvatora
Marsili, Stefania
Francini, Guido
ANNALS OF ONCOLOGY, 2007, 18 : 74 - 74
[25] Current place of chemotherapy in the treatment of hormone-refractory metastatic prostate cancer.
Breton, X
Lechevallier, E
Coulange, C
PROGRES EN UROLOGIE, 2005, 15 (03): : 398 - 404
[26] The role of doxorubicin and epirubicin in the treatment of patients with metastatic hormone-refractory prostate cancer
Petrioli, Roberto
Fiaschi, Anna Ida
Francini, Edoardo
Pascucci, Alessandra
Francini, Guido
CANCER TREATMENT REVIEWS, 2008, 34 (08) : 710 - 718
[27] NICE guidance on cabazitaxel for hormone-refractory metastatic prostate cancer previously treated with a docetaxel-containing regimen
Jilani, Anwar
George, Elisabeth
Adler, Amanda I.
LANCET ONCOLOGY, 2012, 13 (06): : 573 - 574
[28] Atrasentan delays progression of metastatic hormone-refractory prostate cancer
不详
EUROPEAN CYTOKINE NETWORK, 2004, 15 (04) : XII - XII
[29] The current role of chemotherapy in metastatic hormone-refractory prostate cancer
Petrylak, DP
UROLOGY, 2005, 65 (5A) : 3 - 7
[30] New hope for patients with metastatic hormone-refractory prostate cancer
de Wit, Ronald
EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (15) : 817 - 823

← 1 2 3 4 5 →